Mainly used for weight management (Weight Loss) and type 2 diabetes (T2DM) research
Storage Conditions
Before preparation: Refrigerate (2°C~8°C), avoid direct sunlight.
After preparation: It is recommended to store at 2°C~8°C and use within 24-48 hours.
Instructions for Use
Dissolution method:
Use sterile injection water (Bacteriostatic Water, BW) or 0.9% sodium chloride solution (Normal Saline, NS) to dissolve.
Gently rotate the bottle to avoid violent shaking to prevent damage to the protein structure.
Injection method:
Subcutaneous injection (SC), usually once a week. The specific dose needs to be adjusted according to research or doctor's advice.
Recommended injection sites:
Abdomen (avoid 5cm range of navel)
Outer thigh
Outer upper arm (if you need help with injection)
Precautions
Please consult professional medical staff before use.
Maintain aseptic operation during preparation to avoid contamination.
Do not use if discoloration, precipitation, or particles are found.
Frequently Asked Questions (FAQ)
Q1: What are the main research applications for Tirzepatide Powder?
Tirzepatide Powder (10mg/vial) is research-grade and primarily utilized in studies focused on weight management (weight loss) and type 2 diabetes mellitus (T2DM).
Q2: How should Tirzepatide Powder be stored before and after reconstitution?
Before reconstitution, store the lyophilized powder in a refrigerator at 2°C to 8°C away from direct sunlight. Once prepared into a solution, it should be kept refrigerated at 2°C to 8°C and used within 24 to 48 hours.
Q3: What diluents are recommended to dissolve the lyophilized powder?
It is recommended to dissolve the powder using sterile injection water (Bacteriostatic Water, BW) or a 0.9% sodium chloride solution (Normal Saline, NS). Always rotate the vial gently instead of shaking vigorously.
Q4: What is the recommended administration method and frequency?
It is administered via subcutaneous injection (SC), typically given once per week. Specific dosages should always be adjusted according to research protocols or medical guidance.
Q5: Where can subcutaneous injections be administered?
Recommended injection sites include the abdomen (staying at least 5cm away from the navel), the outer thigh, or the outer upper arm.
Q6: What signs indicate that the product should not be used?
Do not use the solution if you observe any discoloration, cloudiness, precipitation, or visible floating particles after dissolution.
